Cargando…
SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response
The emergence of beta-coronavirus SARS-CoV-2 gets entry into its host cells by recognizing angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRESS2) receptors, which are responsible for coronavirus diseases-2019 (COVID-19). Global communities have been affected by COVID-1...
Autores principales: | Hsu, Pi-Ching, Shahed-Al-Mahmud, Md. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490490/ https://www.ncbi.nlm.nih.gov/pubmed/36150465 http://dx.doi.org/10.1016/j.lfs.2022.120981 |
Ejemplares similares
-
CRISPR is a useful biological tool for detecting nucleic acid of SARS-CoV-2 in human clinical samples
por: Rahman, Md. Rashidur, et al.
Publicado: (2021) -
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients
por: Guilmot, Antoine, et al.
Publicado: (2020) -
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
por: Amruta, Narayanappa, et al.
Publicado: (2021) -
Genetic Diversity of SARS-CoV2 and Environmental Settings: Possible Association with Neurological Disorders
por: Hasana, Sharifa, et al.
Publicado: (2021) -
Hypothalamic-Pituitary-Adrenal Axis Activity in SARS-CoV-2 Infected Noncritically Ill Hospitalized Patients
por: Banu, Hurjahan, et al.
Publicado: (2023)